Thursday, November 16, 2017

Nanowired drugs

Nanowired Drugs Could Treat Alzheimer’s and Parkinson’s Patients

by Neuroscience News
Using titanate nanowires treated with cerebrolysin, researchers have been able to target delivery to the brain and through the central nervous system. Researchers report the use of nanowires to deliver drugs could be beneficial in the treatment of Alzheimer's, Parkinson's and other neurodegenerative diseases.
Neuroscience News | November 16, 2017 at 9:12 am | Tags: cerebrolysinnanowirestitanateUniversity of Arkansas | URL: https://wp.me/p4sXNK-bGV
Comment   See all comments

No comments:

Post a Comment